Imagen de Portada

Lifestyle and quality of life in patients with metabolic syndrome and type 2 diabetes

Fuente: Redalyc

Guardado en:

Detalles Bibliográficos
Autor principal:	Yenny Alexandra Granados-Vidal
Formato:	Artículo científico
Lenguaje:	en
Publicado:	Universidad del Magdalena 2019
Materias:	Salud Lifestyle Metabolism Quality of life type 2 Diabetes Metabolic X Syndrome
Acceso en línea:	Acceder al recurso 1 Acceder al recurso 2 Acceder al recurso 3 Acceder al recurso 4 Acceder al recurso 5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Characterization of patients with pre-diabetes in first-level health care service institutions Cali, Colombia
por: FABIO N. FIGUEROA
Publicado: (2011)

Clinical evaluation of diabetic neuropathy in adult patients with type 1 diabetes and its possible association with insulin resistance
por: Claudia González-Milán
Publicado: (2017)

Prevalence of metabolic syndrome among university students: A systematic review
por: Adalberto Campo-Arias
Publicado: (2018)

Glycaemic and weight effects of metabolic surgery or semaglutide in diabetes dosage for patients with type 2 diabetes
por: Erik Stenberg, et al.
Publicado: (2024)

Exercise Intensity and Postprandial Lipemia
por: Laurel A. Littlefield
Publicado: (2015)

Comparison of the impact of type 1 and type 2 diabetes on quality of life of families of patients: A UK cross‐sectional study
por: Rubina Shah, et al.
Publicado: (2024)

An interpretable machine learning model for predicting metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes
por: Zhuolin Zhou, et al.
Publicado: (2025)

Association of KLF14 rs4731702 gene polymorphism with metabolic phenotype in young patients with type 1 diabetes
por: Monika Ryba‐Stanisławowska, et al.
Publicado: (2024)

Natriuretic peptide levels and predicting risk of developing new diabetes mellitus and metabolic syndrome
por: Jasraj Singh, et al.
Publicado: (2024)

Glucagon agonism in the treatment of metabolic diseases including type 2 diabetes mellitus and obesity
por: Jonathan Brix Winther, et al.
Publicado: (2024)

Real‐world impact of tirzepatide on the risk of progression to type 2 diabetes and metabolic outcomes in people with obesity and pre‐diabetes
por: Scott A. Coon, et al.
Publicado: (2025)

The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetes
por: Yves Reznik, et al.
Publicado: (2024)

Prediction of glycaemic control and quality of life in people with type 2 diabetes using glucose‐lowering drugs with machine learning—The Maastricht study
por: Nikki C. C. Werkman, et al.
Publicado: (2025)

Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double‐blind, randomized, placebo‐controlled trial
por: Minji Sohn, et al.
Publicado: (2024)

Health‐related quality of life of people with type 1 diabetes: An IMI2 SOPHIA post hoc analysis of FUTURE and ADJUNCT ‐ ONE
por: Nele Steenackers, et al.
Publicado: (2024)

Key biomarkers in type 2 diabetes patients: A systematic review
por: Thien Ngoc Le, et al.
Publicado: (2024)

Real‐world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus
por: Michael S. Kelly, et al.
Publicado: (2024)

Elucidating the role of weight loss and glycaemic control in patients with type 2 diabetes
por: Anukriti Sharma, et al.
Publicado: (2024)

The association between inflammation and glucose levels in hospitalised patients with type 2 diabetes
por: Mikkel T. Olsen, et al.
Publicado: (2025)

Long‐term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction‐associated fatty liver disease in adults with obesity and type 2 diabetes
por: Michelle D. Lundholm, et al.
Publicado: (2024)

Impact of bariatric surgery on glycaemic and metabolic outcomes in people with obesity and type 2 diabetes mellitus: A meta‐analysis
por: Xu Han, et al.
Publicado: (2025)

Correction to “Real‐world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus”
Publicado: (2024)

Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes
por: Mohmmad Alghamdi, et al.
Publicado: (2025)

Bidirectional association between type 2 diabetes and irritable bowel syndrome: A large‐scale prospective cohort study
por: Yesheng Zhou, et al.
Publicado: (2024)

The cardio‐metabolic protein profile is associated with development of type 2 diabetes at long term follow‐up after gestational diabetes mellitus: Results from the OGFUS study
por: Simone J. Hallig, et al.
Publicado: (2025)

Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes
por: Ebaa Al‐Ozairi, et al.
Publicado: (2024)

Semaglutide improves treatment satisfaction and eating behaviour in Japanese patients with type 2 diabetes mellitus
por: Yusuke Baba, et al.
Publicado: (2024)

Clinically relevant stratification of patients with type 2 diabetes by using continuous glucose monitoring data
por: Xiaopeng Shao, et al.
Publicado: (2024)

An open‐label study on ulotaront's effects on insulin‐glucose regulation in schizophrenia patients with metabolic syndrome and prediabetes: Part I
por: Snezana Milanovic, et al.
Publicado: (2025)

Medical events and costs associated with metabolic bariatric surgery among adults with type 2 diabetes: A retrospective, matched cohort study
por: Kristina S. Boye, et al.
Publicado: (2025)

Pathophysiology of type 2 diabetes: A focus on the metabolic differences among southeast Asian, Chinese and Indian populations and how this impacts treatment
por: Yuzi Cao, et al.
Publicado: (2025)

Glycaemic control metrics and metabolic dysfunction–associated steatotic liver disease in children and adolescents with type 1 diabetes
por: Claudio Maffeis, et al.
Publicado: (2024)

Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes
por: Djordje S. Popovic, et al.
Publicado: (2024)

Long‐acting insulin analogues and the risk of diabetic nephropathy among patients with type 2 diabetes: A population‐based cohort study
por: Julia Brillinger, et al.
Publicado: (2026)

Non‐invasive metabolic biomarkers in initial cognitive impairment in patients with diabetes: A systematic review and meta‐analysis
por: Meng‐Di Chen, et al.
Publicado: (2024)

Sodium‐glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real‐world patients with type 2 diabetes
por: Jingchuan Guo, et al.
Publicado: (2024)

Prediction of new‐onset heart failure in patients with type 2 diabetes derived from ALTITUDE and CANVAS
por: Fatema Said, et al.
Publicado: (2024)

Comparative effectiveness of glucose monitoring methods and glycaemic control in patients with type 2 diabetes: An umbrella review
por: Nathaniel Foo, et al.
Publicado: (2025)

Effects of sotagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease stages 3 and 4
por: Vikas S. Sridhar, et al.
Publicado: (2024)

Carnitine supplementation improves insulin sensitivity and skeletal muscle acetylcarnitine formation in patients with type 2 diabetes
por: Yvonne M. H. Op den Kamp‐Bruls, et al.
Publicado: (2025)